Cortechs.ai | Cortechs.ai Joins Forces with Kryptonite Solutions as a Distribution Partner to Expand AI-Driven Neuroimaging Access in India

Cortechs.ai Joins Forces with Kryptonite Solutions as a Distribution Partner to Expand AI-Driven Neuroimaging Access in India

San Diego, CA – Cortechs.ai, a global leader in AI-powered neuroimaging software, is proud to announce a strategic partnership with Kryptonite Solutions, a renowned provider of advanced MRI solutions. This collaboration will expand the distribution of Cortechs.ai’s innovative portfolio across India, enhancing access to cutting-edge neuroimaging technology for healthcare providers and patients alike.

The partnership brings together Kryptonite Solutions’ extensive distribution network and expertise in MRI patient comfort with Cortechs.ai’s industry-leading AI-driven imaging solutions. This synergy will help radiologists and neurologists across India leverage state-of-the-art software to improve diagnostic accuracy and patient outcomes.

“This partnership with Kryptonite Solutions marks a significant milestone in our mission to enhance neuroimaging capabilities worldwide,” said Kyle Frye, CEO of Cortechs.ai. “India is a rapidly growing healthcare market with an increasing demand for advanced imaging solutions. By collaborating with Kryptonite Solutions, we are ensuring that more healthcare providers can access and benefit from our AI-driven analysis tools, ultimately improving patient care.”

Kryptonite Solutions has built a strong reputation for delivering innovative MRI technologies that prioritize both patient experience and diagnostic efficiency. By integrating Cortechs.ai’s software into their offerings, Kryptonite Solutions aims to provide a more comprehensive imaging solution to hospitals and imaging centers across India.

“This collaboration unites two industry leaders in the medical imaging space, allowing us to bridge the gap between patient-centric MRI solutions and cutting-edge AI-driven diagnostics. Together, we are creating a more seamless and efficient imaging experience for hospitals and imaging centers worldwide,” said Paras Doshi, Founder and Managing Partner at Kryptonite Solutions.

Daniel D’Amour, Director of Global Partnerships at Cortechs.ai, also emphasized the strategic importance of this collaboration: “Kryptonite Solutions’ deep understanding of the Indian healthcare landscape and strong distribution network make them an ideal partner for us. This partnership will allow us to bridge the gap between AI-powered imaging and real-world clinical application, ensuring that patients across India benefit from the latest advancements in neuroimaging.”

By combining Kryptonite Solutions’ patient-centric approach with Cortechs.ai’s AI-driven expertise, this partnership aims to redefine how neurological conditions are diagnosed and managed in India. The collaboration represents a significant leap forward in providing healthcare professionals with the tools they need to make more informed and accurate diagnostic decisions.

For more information about Cortechs.ai and Kryptonite Solutions, visit https://www.cortechs.ai/ and https://kryptonite.global/.

 

About Cortechs.ai

Cortechs.ai is a leader in AI applications in radiology, leveraging advanced technologies in medical imaging to enhance disease screening and early detection, empowering healthcare providers to deliver better outcomes for patients. The company develops and markets innovative medical device software that quantifies and tracks neurodegeneration and prostate cancer, helping clinicians detect and monitor clinically significant cases. Cortechs.ai’s industry-leading imaging solutions offer radiologists, oncologists, and urologists a streamlined, cost-effective way to assess prostate health, including detection and monitoring of cancer. The company also has FDA-cleared products for use in assessing neurological disorders such as Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma, tumors, and other brain abnormalities. For more information, please visit www.cortechs.ai and follow us on Twitter, LinkedIn, and Facebook.

 

For more information, please contact:

___________

[email protected]

+1 858 459 9700

More Resources

07/31/2025

Precision Without the Pressure: Smarter Brain Tumor Monitoring

Learn about NeuroQuant Brain Tumor 2.0 and how it assists clinicians by providing objective quantification and analysis of tumor changes over time.

07/30/2025

Cortechs.ai Announce Next-Gen NeuroQuant Brain Tumor: AI-Driven Metastasis & Meningioma Segmentation 

NeuroQuant Brain Tumor is the first FDA-cleared, cloud-native tool to offer automated volumetric segmentation for brain metastases, meningiomas, and gliomas.

07/28/2025

Longitudinal Assessment of Traumatic Brain Injury Using NeuroQuant®

A case study with Dr. Suzie Bash on NeuroQuant as a reliable, reimbursable, and efficient tool in the evaluation and follow-up of TBI.

07/24/2025

Understanding the Hippocampal Occupancy Score

One of the most frequently asked questions among customers is, “What does the Hippocampal Occupancy Score (HOC) represent within the Dementia Report?”

07/16/2025

Advancing Prostate MRI with Restriction Spectrum Imaging

Why is OnQ Prostate unique, and what makes it a game-changer for clinicians?

07/08/2025

Enhancing Neuroimaging Insights: LVV & ICV Quantification and Midline Shift Indexing with NeuroAlign CT

Time-sensitive and precise diagnostic imaging can mean the difference between rapid intervention and devastating outcomes.
Scroll to Top